Schedule 13D ownership disclosure
REED'S, INC.
Common Stock · CUSIP: 758338305
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Era Regenerative Medicine LtdReported CIK 0002053961
Shares: 27,139,519.00 · Class: 59.5%
- D&D Source of Life Holding Ltd.Reported CIK 0001979652
Shares: 27,139,519.00 · Class: 59.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-008594
- Form type
- SCHEDULE 13D
- Filer
- Era Regenerative Medicine Ltd
- CIK
- CIK 2053961
- Filed
- Feb 28, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13D beneficial ownership